A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)-Reference-Cited by-同舟云学术

A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)

Published:2021-02 Issue: Volume: Page:
ISSN:2405-4569
Container-title:European Urology Focus
language:en
Short-container-title:European Urology Focus

Author:

Wu Zhenjie,Chen Qi,Djaladat Hooman,Minervini Andrea,Uzzo Robert G.,Sundaram Chandru P.,Rha Koon H.,Gonzalgo Mark L.,Mehrazin Reza,Mazzone Elio,Marcus Jamil,Danno Alyssa,Porter James,Asghar Aeen,Ghali Fady,Guruli Georgi,Douglawi Antoin,Cacciamani Giovanni,Ghoreifi Alireza,Simone Giuseppe,Margulis Vitaly,Ferro Matteo,Tellini Riccardo,Mari Andrea,Srivastava Abhishek,Steward James,Al-Qathani Ali,Al-Mujalhem Ahmad,Bhattu Amit Satish,Mottrie Alexander,Abdollah Firas,Eun Daniel D.,Derweesh Ithaar,Veccia Alessandro,Autorino Riccardo,Wang Linhui^ORCID

Funder

Shanghai Shenkang Hospital Development Center

Shanghai Municipal Health Bureau

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Urology

Reference28 articles.

1. Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial;Birtle;Lancet,2020

2. Leow JJ, Chong YL, Chang SL, Valderrama BP, Powles T, Bellmunt J. Neoadjuvant and adjuvant chemotherapy for upper tract urothelial carcinoma: a 2020 systematic review and meta-analysis, and future perspectives on systemic therapy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.07.003.

3. Impact of contemporary patterns of chemotherapy utilization on survival in patients with advanced cancer of the urinary tract: a Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC);Bamias;Ann Oncol,2018